Taux de reproduction de base : Questions médicales fréquentes
Nom anglais: Basic Reproduction Number
Descriptor UI:D050936
Tree Number:N06.850.520.308.985.525.080
Termes MeSH sélectionnés :
Cholangiocarcinoma
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Taux de reproduction de base : Questions médicales les plus fréquentes",
"headline": "Taux de reproduction de base : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Taux de reproduction de base : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-08",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Taux de reproduction de base"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Morbidité",
"url": "https://questionsmedicales.fr/mesh/D009017",
"about": {
"@type": "MedicalCondition",
"name": "Morbidité",
"code": {
"@type": "MedicalCode",
"code": "D009017",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.525"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Taux de reproduction de base",
"alternateName": "Basic Reproduction Number",
"code": {
"@type": "MedicalCode",
"code": "D050936",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jun-Sik Lim",
"url": "https://questionsmedicales.fr/author/Jun-Sik%20Lim",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, Korea."
}
},
{
"@type": "Person",
"name": "Son-Il Pak",
"url": "https://questionsmedicales.fr/author/Son-Il%20Pak",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, Korea."
}
},
{
"@type": "Person",
"name": "Jane M Heffernan",
"url": "https://questionsmedicales.fr/author/Jane%20M%20Heffernan",
"affiliation": {
"@type": "Organization",
"name": "Mathematics & Statistics, York University, Toronto, Canada."
}
},
{
"@type": "Person",
"name": "Dimitri Breda",
"url": "https://questionsmedicales.fr/author/Dimitri%20Breda",
"affiliation": {
"@type": "Organization",
"name": "CDLab - Computational Dynamics Laboratory, Department of Mathematics, Computer Science and Physics - University of Udine, via delle scienze 206, 33100 Udine, Italy."
}
},
{
"@type": "Person",
"name": "Jordi Ripoll",
"url": "https://questionsmedicales.fr/author/Jordi%20Ripoll",
"affiliation": {
"@type": "Organization",
"name": "Department of Computer Science, Applied Mathematics and Statistics - University of Girona, Campus Montilivi, 17003 Girona, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Current Studies and Evidence in Cholangiocarcinoma].",
"datePublished": "2022-07-21",
"url": "https://questionsmedicales.fr/article/35863357",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1844-0267"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pemigatinib: A Review in Advanced Cholangiocarcinoma.",
"datePublished": "2024-01-11",
"url": "https://questionsmedicales.fr/article/38206555",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11523-023-01024-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Challenges in Diagnosing and Reporting Cholangiocarcinoma.",
"datePublished": "2023-06-23",
"url": "https://questionsmedicales.fr/article/37536891",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.path.2023.04.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endoscopic management of perihilar cholangiocarcinoma.",
"datePublished": "2022-06-02",
"url": "https://questionsmedicales.fr/article/35377509",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/den.14317"
}
},
{
"@type": "ScholarlyArticle",
"name": "\"Long-term follow-up of liver transplantation in incidental intrahepatic cholangiocarcinoma and mixed hepatocellular-cholangiocarcinoma\".",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/37119950",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cireng.2023.04.010"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Collecte de données",
"item": "https://questionsmedicales.fr/mesh/D003625"
},
{
"@type": "ListItem",
"position": 6,
"name": "Registre civil",
"item": "https://questionsmedicales.fr/mesh/D014798"
},
{
"@type": "ListItem",
"position": 7,
"name": "Morbidité",
"item": "https://questionsmedicales.fr/mesh/D009017"
},
{
"@type": "ListItem",
"position": 8,
"name": "Taux de reproduction de base",
"item": "https://questionsmedicales.fr/mesh/D050936"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Taux de reproduction de base - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Taux de reproduction de base",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Taux de reproduction de base",
"description": "Comment évaluer le taux de reproduction de base ?\nQuels outils sont utilisés pour calculer le R0 ?\nLe R0 peut-il varier selon les épidémies ?\nQuelles données sont nécessaires pour le calcul du R0 ?\nLe R0 est-il constant dans le temps ?",
"url": "https://questionsmedicales.fr/mesh/D050936?mesh_terms=Cholangiocarcinoma&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Taux de reproduction de base",
"description": "Quels symptômes sont liés à un R0 élevé ?\nLe R0 influence-t-il la gravité des symptômes ?\nLes symptômes varient-ils selon le R0 ?\nComment le R0 affecte-t-il la détection des symptômes ?\nLe R0 a-t-il un impact sur les symptômes chez les groupes vulnérables ?",
"url": "https://questionsmedicales.fr/mesh/D050936?mesh_terms=Cholangiocarcinoma&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Taux de reproduction de base",
"description": "Comment réduire le R0 dans une épidémie ?\nLe port du masque influence-t-il le R0 ?\nLes campagnes de sensibilisation affectent-elles le R0 ?\nLe R0 peut-il être contrôlé par la vaccination ?\nLes mesures de quarantaine influencent-elles le R0 ?",
"url": "https://questionsmedicales.fr/mesh/D050936?mesh_terms=Cholangiocarcinoma&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Taux de reproduction de base",
"description": "Le R0 influence-t-il les options de traitement ?\nComment le R0 affecte-t-il la recherche de traitements ?\nLes traitements varient-ils selon le R0 ?\nLe R0 impacte-t-il la disponibilité des traitements ?\nLes traitements préventifs dépendent-ils du R0 ?",
"url": "https://questionsmedicales.fr/mesh/D050936?mesh_terms=Cholangiocarcinoma&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Taux de reproduction de base",
"description": "Un R0 élevé entraîne-t-il des complications ?\nQuelles complications sont liées à un R0 élevé ?\nLe R0 affecte-t-il les complications à long terme ?\nLes complications varient-elles selon le R0 ?\nComment le R0 influence-t-il les soins post-infection ?",
"url": "https://questionsmedicales.fr/mesh/D050936?mesh_terms=Cholangiocarcinoma&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Taux de reproduction de base",
"description": "Quels facteurs augmentent le R0 ?\nLes conditions de santé influencent-elles le R0 ?\nLe climat affecte-t-il le R0 ?\nLes voyages internationaux influencent-ils le R0 ?\nLes interventions de santé publique peuvent-elles réduire le R0 ?",
"url": "https://questionsmedicales.fr/mesh/D050936?mesh_terms=Cholangiocarcinoma&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer le taux de reproduction de base ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le R0 est estimé par des modèles épidémiologiques basés sur les données de transmission."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour calculer le R0 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des outils statistiques et des simulations informatiques sont utilisés pour le calcul."
}
},
{
"@type": "Question",
"name": "Le R0 peut-il varier selon les épidémies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le R0 varie selon le pathogène, la population et les conditions environnementales."
}
},
{
"@type": "Question",
"name": "Quelles données sont nécessaires pour le calcul du R0 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les données sur les taux d'infection, la durée de contagiosité et la population sont essentielles."
}
},
{
"@type": "Question",
"name": "Le R0 est-il constant dans le temps ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le R0 peut changer avec les interventions de santé publique et l'immunité de la population."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à un R0 élevé ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un R0 élevé peut entraîner une propagation rapide, augmentant les cas symptomatiques."
}
},
{
"@type": "Question",
"name": "Le R0 influence-t-il la gravité des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le R0 ne détermine pas la gravité, mais une transmission rapide peut saturer les systèmes de santé."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le R0 ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes dépendent du pathogène, pas directement du R0."
}
},
{
"@type": "Question",
"name": "Comment le R0 affecte-t-il la détection des symptômes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un R0 élevé peut rendre difficile la détection précoce des symptômes dans une épidémie."
}
},
{
"@type": "Question",
"name": "Le R0 a-t-il un impact sur les symptômes chez les groupes vulnérables ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes vulnérables peuvent présenter des symptômes plus graves avec un R0 élevé."
}
},
{
"@type": "Question",
"name": "Comment réduire le R0 dans une épidémie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures comme la distanciation sociale et la vaccination peuvent réduire le R0."
}
},
{
"@type": "Question",
"name": "Le port du masque influence-t-il le R0 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port du masque peut réduire la transmission et donc le R0."
}
},
{
"@type": "Question",
"name": "Les campagnes de sensibilisation affectent-elles le R0 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent améliorer les comportements préventifs et réduire le R0."
}
},
{
"@type": "Question",
"name": "Le R0 peut-il être contrôlé par la vaccination ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une couverture vaccinale élevée peut réduire le R0 et contrôler l'épidémie."
}
},
{
"@type": "Question",
"name": "Les mesures de quarantaine influencent-elles le R0 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la quarantaine peut limiter la propagation et réduire le R0."
}
},
{
"@type": "Question",
"name": "Le R0 influence-t-il les options de traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un R0 élevé peut nécessiter des traitements plus agressifs pour contrôler l'épidémie."
}
},
{
"@type": "Question",
"name": "Comment le R0 affecte-t-il la recherche de traitements ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un R0 élevé stimule la recherche rapide de traitements et de vaccins efficaces."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le R0 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction de la transmissibilité du pathogène."
}
},
{
"@type": "Question",
"name": "Le R0 impacte-t-il la disponibilité des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un R0 élevé peut entraîner une demande accrue, rendant les traitements moins disponibles."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs dépendent-ils du R0 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le R0 guide les stratégies de traitement préventif pour limiter la propagation."
}
},
{
"@type": "Question",
"name": "Un R0 élevé entraîne-t-il des complications ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un R0 élevé peut saturer les systèmes de santé, entraînant des complications."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à un R0 élevé ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des hospitalisations massives et des décès accrus."
}
},
{
"@type": "Question",
"name": "Le R0 affecte-t-il les complications à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une transmission rapide peut augmenter le risque de complications à long terme."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le R0 ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent varier selon le pathogène et le R0 associé."
}
},
{
"@type": "Question",
"name": "Comment le R0 influence-t-il les soins post-infection ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un R0 élevé peut nécessiter des soins post-infection plus intensifs en raison des complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le R0 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "La densité de population, les comportements sociaux et la mobilité augmentent le R0."
}
},
{
"@type": "Question",
"name": "Les conditions de santé influencent-elles le R0 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conditions de santé préexistantes peuvent augmenter le R0 en rendant les individus plus susceptibles."
}
},
{
"@type": "Question",
"name": "Le climat affecte-t-il le R0 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains pathogènes sont plus transmissibles dans des conditions climatiques spécifiques."
}
},
{
"@type": "Question",
"name": "Les voyages internationaux influencent-ils le R0 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent introduire des pathogènes et augmenter le R0 dans de nouvelles régions."
}
},
{
"@type": "Question",
"name": "Les interventions de santé publique peuvent-elles réduire le R0 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interventions ciblées peuvent réduire le R0 en limitant la transmission."
}
}
]
}
]
}
Cholangiocarcinoma (CCA) is the second most common type of primary liver cancer and includes a group of intra- and extrahepatic bile tract cancers. Prognosis of patients with CCA remains poor due to h...
Intrahepatic cholangiocarcinoma is a challenge to the practicing surgical pathologist for several reasons. It is rare in many parts of the world, and thus practical exposure may be limited. Related to...
Endoscopic management for perihilar cholangiocarcinoma (PHCC) is evolving toward more accurate diagnosis and safer drainage. In imaging, it is important to diagnose the entire lesion using multidetect...
The standard treatment for intrahepatic cholangiocarcinoma (iCCA) and mixed hepatocellular-cholangiocarcinoma (HCC-CC) is surgical resection, nevertheless, recent studies show adequate survival rates ...
A retrospective cohort study was design including all patients undergoing LT at our center between January, 2006 and December, 2019 with incidentally diagnosed iCCA or HCC-CC after pathological examin...
There were no iCCA or HCC-CC recurrences during the follow-up, and hence, there were no tumor related deaths. Global and disease-free survival were the same. The 1, 3 and 5-years patient survival were...
These results suggest that LT could be an option in patients with chronic liver disease who develop an iCCA or HCC-CC, even in highly selected advanced tumors, but we must be cautious when analyzing t...
This study aimed to elucidate the safety and oncological outcomes of surgery with hepatic artery resection (HAR) for patients with distal cholangiocarcinoma....
The clinical data of patients with distal cholangiocarcinoma who underwent curative intent surgery at Hiroshima University between March 2009 and January 2021 were retrospectively analyzed. Eligible p...
Among the 60 patients analyzed, eight patients had received HAR, and the remaining 52 patients had not. The rate of portal vein resection, T stage, and the number of metastasized lymph nodes in the HA...
Patients with distal cholangiocarcinoma who underwent surgery with HAR tended to show early recurrences, although HAR could be performed safely....
Cholangiocarcinoma (CCA) is the second most frequent primary liver cancer, following hepatocellular carcinoma (HCC). Progress in the molecular understanding of CCA has led to the development of severa...
Intrahepatic cholangiocarcinoma (ICC), highly invasive and highly heterogeneous, has a poor prognosis. It has been confirmed that many risk factors are associated with ICC including intrahepatic lithi...
The occurrence of a cluster of occupational cholangiocarcinoma(CCA) cases among Japanese workers at a small offset printing plant led to the hypotheses that occupational exposure was the root cause of...
To conduct a systematic review on the cause of CCA in relation to occupation....
The systematic review included papers published between 1980 and 2020. Databases included PubMed, Science Direct, CINAHL, ProQuest Medical Library, Springer, Wiley online library, and the Cochrane lib...
The review revealed that ten observational studies met the eligibility criteria. There was heterogeneity of occupational exposure assessment and the reported results. The possible carcinogens statisti...
Despite the limited number of studies reviewed, the hypothesis of occupational risk for CCA was supported. Occupational health and safety measures may decrease exposure to these carcinogens, and surve...
To clarify the pathological significance of two precursors (high-grade biliary intraepithelial neoplasm [BilIN] and intraductal papillary neoplasm of bile duct [IPNB]) in cholangiocarcinomas (CCAs)....
Ninety-one cases of CCA (47 distal CCAs [dCCAs], 31 perihilar CCAs [pCCAs] and 13 intrahepatic CCAs of large duct type [LD-iCCAs]) were examined for their association with precursors. Neoplastic intra...
Fifty-four and 8 of 91 CCAs were associated with high-grade BilIN and IPNB, respectively, while these precursors were unidentifiable in the remaining CCAs. A majority of CCAs were of the gastrobiliary...
CCAs were frequently associated with precursors; high-grade BilIN may be a major precursor and IPNB a minor one. CCAs with IPNB showed a favorable postoperative OS compared to CCAs with high-grade Bil...